Y. Michael Twersky concentrates his practice on complex
litigation, including primarily on insurance, antitrust, and
In the past, Mr. Twersky has worked on a wide variety of
insurance matters including an insurance case in which a Federal
District Court found (on Summary Judgement) that a large insurance
company had breached its policy when it denied benefits under an
accidental death insurance plan. Mr. Twersky has also worked on a
number of antitrust class actions alleging that pharmaceutical
manufacturers wrongfully kept less expensive generic drugs off the
market, in violation of the antitrust laws, including In re
Skelaxin (Metaxalone) Antitrust Litigation, 1:12-md-02343 (E.D.
Tenn.) ($73 million settlement).
Currently Mr. Twersky is involved in a number of complex class
cases, including In Re Global Tel*Link Corporation ICS
Litigation, 14-cv-5275 (W.D. Ark.), and Mojica v.
Securus Technologies, Inc. 14-cv-5258 (W.D. Ark.) alleging
that pursuant to the Federal Communication Act providers of inmate
phone services have overcharged inmates for inmate calling
services; South Peninsula Hospital et al v. Xerox State
Healthcare, LLC, 3:15-cv-00177 (D. Ak.) brought on behalf of
Alaska-enrolled Medicaid Healthcare Providers against the
developers of the Alaska Medicaid Management Information System
Company alleging that providers were harmed as a result of the
negligent and faulty design and implementation of the MMIS system;
In re Solodyn Antitrust Litig., 14 MD 2503 (D. Mass.)
alleging that a pharmaceutical manufacturer has wrongfully impeded
generic drug competition, in violation of the federal antitrust
laws. Mr. Twersky is also involved in environmental litigation on
behalf of various states to recover the costs of remediation for
contamination to the groundwater resources.
Mr. Twersky graduated from Temple University Beasley School of
Law in 2011, where he was a member of the Rubin Public Interest Law
Honors Society and a Class Senator. In addition Mr. Twersky
advised various clients in business matters as part of Temple
University's Business Law Clinic.